Fluvoxamine (brand name Luvox) is an antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI).
Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of obsessive compulsive disorder (OCD).
Fluvoxamine CR (controlled release) is approved to treat social anxiety disorder.
Fluvoxamine is also prescribed to treat major depressive disorder (MDD) and anxiety disorders, such as panic disorder and post-traumatic stress disorder (PTSD).
| Fluvoxamine Pellets Systematic (IUPAC) Name | Fluvoxamine Pellets Identifiers | Fluvoxamine Pellets Chemical data |
|---|---|---|
| (E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-2-aminoethyl oxime |
|
|
We supply Fluvoxamine in pellets form and granules form. Our Fluvoxamine Pellets can be used in a variety of Pharmaceutical applications like It can be used in tablets and capsules.
We also offer Sustained Release(SR) / Immediate Release (IR) and Enteric Coated (EC) Fluvoxamine Pellets.
Umang pharmatech has the capability to manufacture Fluvoxamine Pellets of various particle sizes.
